PATENT CLAIM ANALYSIS

Application Number: 15766029
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["424", "049000"]

Abstract:
A bactericidal and virucidal pharmaceutical composition for use on epithelial tissues such as pulmonary, nasal and oral tissues, which comprises a non-steroidal anti-inflammatory drug (NSAID) in a concentration between 5 and 500 mM and a salt, being the NSAID preferably solubilized in a hypertonic saline solution applicable in therapies for viral infections of the Herpes simplex type. The composition can be used in therapies for herpes simplex viral infections, be used as a bactericidal mouthwash, or be vehiculated to the lung by using a nebuliser, for cystic fibrosis.

Claim (Index 4):
The composition of  claim 1 , wherein said NSAID comprises a concentration between 5 and 180 mM and is selected from the group consisting of ibuprofen, naproxen, flurbiprofen, ketoprofen, diclofenac, diflunisal, etodolac, fenoprofen, indomethacin, meclofenamate, mefenamic acid, meloxicam, nabumetone, oxaprozin, piroxicam, sulindac, tolmetin, celecoxib, acetylated salicylates, non-acetylated salicylates, and combinations thereof.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 91.0
- Lexical Diversity: 1.53125
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['11249051', '14069001', '12995125', '14791210', '13605734']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7598979804694468
- 35 USC 102 Novelty (BERT): 0.4802329834941441
- Combined Prediction Score: 0.7319314807719166
- Mean Citation Score: 198.27391
- Max Citation Score: 210.70003
- Similarity Product: 164.65503675490737

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test